Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer’s disease

@inproceedings{HerasSandoval2016RoleOD,
  title={Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer’s disease},
  author={David Heras-Sandoval and Jos{\'e} Pedraza-Chaverri and Jazmin M P{\'e}rez-Rojas},
  booktitle={Journal of Neuroinflammation},
  year={2016}
}
Docosahexaenoic acid (DHA) is an omega-3 (ω-3) long-chain polyunsaturated fatty acid (LCPUFA) relevant for brain function. It has largely been explored as a potential candidate to treat Alzheimer’s disease (AD). Clinical evidence favors a role for DHA in the improvement of cognition in very early stages of the AD. In response to stress or damage, DHA generates oxygenated derivatives called docosanoids that can activate the peroxisome proliferator-activated receptor γ (PPARγ). In conjunction… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 7 times over the past 90 days. VIEW TWEETS
9 Citations
133 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 133 references

Similar Papers

Loading similar papers…